Literature DB >> 12897375

Mortality rate of chronically ill geriatric patients with subnormal serum thyrotropin concentration: a 2-yr follow-up study.

Andrea Radácsi1, Gábor Kovács, Wolfdieter Bernard, Joachim Feldkamp, Franz A Horster, István Szabolcs.   

Abstract

We investigated the natural course of subclinical thyroid dysfunctions in geriatric patients, especially regarding their association with mortality rate. Ninety-three randomly selected chronically ill geriatric patients 64- 87 (median: 77) yr of age participated in the screening study with a 2-yr follow-up. Serum thyrotropin (thyroid- stimulating hormone [TSH]), free thyroxine, triiodothyronine, and antibodies against thyroid peroxidase were measured. During the follow-up, patients with suppressed TSH levels who were otherwise euthyroid (untreated) had a higher mortality rate than patients with normal TSH (5/8 vs 18/64; p < 0.05). The initial clinical state of these two subgroups did not differ significantly. Two-thirds of patients with treated hyperthyroidism died. The mortality rate of patients with initially subnormal but not suppressed TSH level was average and did not differ statistically from either the euthyroid or the hyperthyroid groups. Only 1 of 13 euthyroid patients with positive thyroid antibody titers developed a subsequent subclinical hypothyroidism. Subclinical hyperthyroidism was found to be associated with a higher mortality rate in chronically ill geriatric patients, which justifies screening for thyroid dysfunction and treatment of subclinical hyperthyroidism. In addition, a subnormal but measurable TSH was not indicative regarding the future development of hyperthyroidism. Finally, during the 2-yr follow-up, antibody positivity in the euthyroid cases did not prove to be predictive for the subsequent development of hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12897375     DOI: 10.1385/endo:21:2:133

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  27 in total

Review 1.  Clinical practice. Subclinical hyperthyroidism.

Authors:  A D Toft
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

2.  Screening for thyroid disease in the elderly. Serum free thyroxine and thyrotropin concentrations in a representative population of 81-year-old women and men.

Authors:  G Sundbeck; P A Lundberg; G Lindstedt; A Svanborg; S Edén
Journal:  Aging (Milano)       Date:  1991-03

Review 3.  Subclinical thyroid disease.

Authors:  V Fatourechi
Journal:  Mayo Clin Proc       Date:  2001-04       Impact factor: 7.616

4.  Subclinical thyroid dysfunction in the elderly.

Authors:  J J Jayme; P W Ladenson
Journal:  Trends Endocrinol Metab       Date:  1994-03       Impact factor: 12.015

5.  Utility of third generation thyrotropin assays in thyroid function testing.

Authors:  B Saller; N Broda; R Heydarian; R Görges; K Mann
Journal:  Exp Clin Endocrinol Diabetes       Date:  1998       Impact factor: 2.949

6.  Subclinical thyroid disease.

Authors:  M I Surks; E Ocampo
Journal:  Am J Med       Date:  1996-02       Impact factor: 4.965

7.  Subclinical hyperthyroidism--just a low serum thyrotropin concentration, or something more?

Authors:  R D Utiger
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

Review 8.  [Is there a need for treatment in subclinical hypo- and hyperthyroidism?].

Authors:  M Lerch; C Meier; J J Staub
Journal:  Ther Umsch       Date:  1999-07

9.  Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study.

Authors:  J V Parle; P Maisonneuve; M C Sheppard; P Boyle; J A Franklyn
Journal:  Lancet       Date:  2001-09-15       Impact factor: 79.321

10.  The prevalence of thyroid dysfunction in a population with borderline iodine deficiency.

Authors:  N Knudsen; T Jorgensen; S Rasmussen; E Christiansen; H Perrild
Journal:  Clin Endocrinol (Oxf)       Date:  1999-09       Impact factor: 3.478

View more
  5 in total

Review 1.  A review of the evidence for and against increased mortality in hypothyroidism.

Authors:  Marianne Thvilum; Frans Brandt; Thomas H Brix; Laszlo Hegedüs
Journal:  Nat Rev Endocrinol       Date:  2012-03-06       Impact factor: 43.330

2.  Subclinical hyperthyroidism in patients with type 2 diabetes.

Authors:  Juan J Díez; Pedro Iglesias
Journal:  Endocrine       Date:  2012-02-12       Impact factor: 3.633

3.  Excess mortality in patients diagnosed with hypothyroidism: a nationwide cohort study of singletons and twins.

Authors:  Marianne Thvilum; Frans Brandt; Dorthe Almind; Kaare Christensen; Laszlo Hegedüs; Thomas Heiberg Brix
Journal:  J Clin Endocrinol Metab       Date:  2013-01-30       Impact factor: 5.958

4.  Duration of thyroid dysfunction correlates with all-cause mortality. the OPENTHYRO Register Cohort.

Authors:  Anne Sofie Laulund; Mads Nybo; Thomas Heiberg Brix; Bo Abrahamsen; Henrik Løvendahl Jørgensen; Laszlo Hegedüs
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

5.  Thyroid status and 6-year mortality in elderly people living in a mildly iodine-deficient area: the aging in the Chianti Area Study.

Authors:  Graziano Ceresini; Gian Paolo Ceda; Fulvio Lauretani; Marcello Maggio; Elisa Usberti; Michela Marina; Stefania Bandinelli; Jack M Guralnik; Giorgio Valenti; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2013-05-06       Impact factor: 7.538

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.